Policy / Pricing UniQure, Replimune shares rise as FDA’s Makary exits, but path forward unchanged pharminent May 13, 2026
Clinical Data BridgeBio stands up to Pfizer in ATTR-CM as late-stage data hint at better survival pharminent May 12, 2026
Policy / Pricing 340B in 2026: Market Shifts, Policy Battles, and What They Mean for Stakeholders (NEW Live Video Webinar) pharminent May 12, 2026
Policy / Pricing What to Know About the BALANCE Model for GLP-1s in Medicare and Medicaid and the Medicare GLP-1 Bridge pharminent May 11, 2026
Regulatory Partner’s Bizengri cleared by FDA for ultra-rare cancer days after winning priority voucher pharminent May 11, 2026
Regulatory Biogen, Eisai hit with 3-month delay for starting SubQ Alzheimer’s therapy pharminent May 8, 2026
Commercial Novo’s CEO champions “record-breaking start” for Wegovy pill in US market pharminent May 8, 2026
M&A / Deals UCB and Cancer Research UK form expanded alliance to advance novel cancer therapies pharminent May 7, 2026
Regulatory FDA Expands AI Capabilities and Completes Data Platform Consolidation pharminent May 6, 2026
M&A / Deals Bayer to buy Perfuse for up to $2.45B, bolstering eye drug pipeline pharminent May 6, 2026
Regulatory FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight pharminent May 6, 2026
Commercial Novo’s Wegovy pill reaches 1M patients, shattering expectations with $355M in sales pharminent May 6, 2026
M&A / Deals CellCentric secures $220M in Europe’s biggest private biotech fundraise of 2026 pharminent May 6, 2026
M&A / Deals CellCentric raises $220M for a ‘transformative’ multiple myeloma medicine pharminent May 6, 2026
